ESC 365 - The impact of interventional or medical therapy on the quality of life assessment in patients suffering from supraventricular tachycardias.

EHRA Premium Access

The impact of interventional or medical therapy on the quality of life assessment in patients suffering from supraventricular tachycardias.

Session: Poster session 1 - Supra ventricular tachycardia

Topic: Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome

Speaker: Professor N. Fragakis (Thessaloniki, GR)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Nikolaos Fragakis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

1 presentation

0 follower

8 more presentations in this session

Routine zero-fluoroscopy approach for right-sided EP procedures

Current management of adult asymptomatic patients with the Wolff-Parkinson-White syndrome: More than the guidelines

Speaker: Doctor J. Rubio Campal (Madrid, ES)

Radio frequency ablation of the cavotricuspid isthmus in typical atrial flutter coupled with atrial fibrillation

Speaker: Doctor K. Yergeshov (Almaty, KZ)

Ivabradine as a prevention treatment of inappropriate sinus node tachycardia recurrence

Speaker: Professor S. Grigoryan (Yerevan, AM)

3D pace-mapping of Koch's triangle to reduce risk of unexpected atrioventricular block during zero-X-ray ablation of atrioventricular nodal reentrant tachycardia. A pilot study.

Access the full session

Poster session 1 - Supra ventricular tachycardia

Speakers: Professor N. Fragakis, Doctor J. Rubio Campal, Doctor K. Yergeshov, Professor S. Grigoryan

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources